TRIUMPH-1 es un ensayo fase 3, multicntrico (13 pases), doble ciego y controlado con placebo, que incluy a 2.339 adultos con obesidad o sobrepeso sin DM2, tratados durante 80 semanas, con una extensin preespecificada hasta las 104 semanas en quienes partan de un IMC 35 kg/m
A few commenters expressed concern that the reduced timeframe encourages hospitals, REHs, or ASCs to divert critical staff at a time they are needed most and would force them to prioritize paperwork over patient care, undermining the goals of the CMS quality reporting and value programs
Probiotics have been shown to be potentially effective in reducing diarrhea duration and frequency, though these data were gathered on children and may not be applicable to adults on semaglutide
Increasing NRF2 activity has been proposed as a treatment approach for bipolar disorder, and activating the CaMKK2 signalling pathway represents a potential and viable mechanism to achieve this outcome [209]
Glutathione deficiency in Parkinsons disease: intranasal administration as a method of augmentation